Virtual Roundtable on leveraging private investment in health and life sciences
Investments in health innovation will be central to ensure better preparedness as we are aiming both to recover from the pandemic and to better anticipate future health challenges. Attendees will have the opportunity to:
- Explore the nexus between the private investment and health agendas
- Discuss how policy makers can scale up investments in health and life science innovation
- Exchange with industry experts, OECD and government representatives
In partnership with Business at OECD, Jonhson&Johnson, EuropaBio and BioMed Alliance, EU-LIFE will provide the perspective from stakeholders in the session "Towards an enabling life science ecosystem", with panellists:
- Wilfried Ellmeier, President Biomedical Alliance in Europe
- Marta Dias Agostinho, Executive Director EU-LIFE
- Claire Skentelbery, Director General EuropaBio
- Olivier Grumel, Senior Director, Government Affairs & Policy, Johnson & Johnson
